Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-31
1998-03-31
MacMillan, Keith
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01D 4302, C07D30514
Patent
active
057338884
ABSTRACT:
A pharmaceutical formulation of taxol and polyethoxylated castor oil is disclosed to be relatively acidified to a pH of less than 8.1 and preferably within a pH range of 5 to 7, inclusively, by an acidifying agent. Ethanol is optionally included in the formulation which is adapted for use in a body for the treatment of cancer. A formulation method is disclosed and includes the step of mixing an acid with a carrier material, such as polyethoxylated castor oil, to form a carrier solution after which taxol is added in an amount such that the resulting pH is less than 8.1 and preferably in a pH range of 5 to 7. Ethanol may optionally be slurried with the taxol before mixing with the carrier solution. A variety of acidifying agents, a preferred one being anhydrous citric acid, are described.
REFERENCES:
patent: 4814470 (1989-03-01), Colin et al.
patent: 4942184 (1990-07-01), Haugwitz et al.
patent: 4960790 (1990-10-01), Stella et al.
patent: 5157049 (1992-10-01), Haugwitz et al.
patent: 5254580 (1993-10-01), Chen et al.
patent: 5504102 (1996-04-01), Agharkar et al.
Richheimer, Steven L., David M. Tinnermeier and Daniel W. Timmons (1992) "High-Performance Liquid Chromatographic Assay Of Taxol" Anal. Chem. 64:2323-2326.
Ringel, Israel, Susan Band Horwitz (1987) "Taxol is Converted to 7-Epitaxol, a Biologically Active Isomer, in Cell Culture Medium" Journal of Pharmacology and Experimental Therapeutics 242(1)692-698.
Kingston, David G. I. (1991) "The Chemistry of Taxol" Pharmac. Ther. 52:1-34.
Kingston, David, G. I., Neal F. Magri, Chote Jitrangsri (1986) "Synthesis And Structure-Activity Relationships of Taxol Derivatives As Anticancer Agents" Studies In Organic Chemistry 26:219-235.
Magri, Neal F. and David G.I. Kingston (1986) "Modified Taxols. 2. Oxidation Products of Taxol" Journal of Org. Chem. 51:797-802.
Stability, compatability, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers, Reports Taxol, vol. 48, Jul. 1991 by Wanda N. Waugh, Lawrence A. Trissel and Valentino J. Stella.
High-Performance Liquid Chromatographic Assay for Taxol in Human Plasma and Pharmacokinetics in Phase I Trial, Cancer Treatment Reports, vol. 71, No. 1, Jan. 1987 by Stephen M. Longnecker, et al.
Carver David
Elliott Robyn
Ewald Hernita
Handreck Paul
Prout Timothy
MacMillan Keith
NaPro BioTherapeutics, Inc.
LandOfFree
Injectable composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-52025